March 06, 2009

Gilead Sciences to Present at the Barclays Capital Global Healthcare Conference on Tuesday, March 10

Webcast Available Through Gilead Corporate Website

John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company on Tuesday, March 10 at 10:15 a.m. Eastern Time.

To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc.Susan Hubbard, 650-522-5715Investor Relations

Investors

Jacquie Ross
investors_relations@gilead.com

Media Contact

Meaghan Smith
public_affairs@gilead.com

Other News

Some of the content on this page is not intended for users outside the U.S.